Posts With Tag NASDAQ ABUS

Showing 1 - 2 of 2 Posts

Arbutus Biopharma's 8-K Report: Key Updates for Investors on February 24, 2025

•

Form 8-K

•

2025-02-25

Last updated: about 1 month ago

Arbutus Biopharma's 8-K Report: Key Updates for Investors on February 24, 2025

Discover crucial insights from Arbutus Biopharma Corporation's Form 8-K filing detailing significant events affecting ABUS stock. Stay informed about recent developments!

Arbutus Biopharma biotechnology Form 8-K NASDAQ ABUS financial reporting

Arbutus Biopharma 8-K Report: Key Event Insights from January 13, 2025

•

Form 8-K

•

2025-01-13

Last updated: 4 months ago

Arbutus Biopharma 8-K Report: Key Event Insights from January 13, 2025

Explore Arbutus Biopharma's 8-K filing detailing a significant event on January 13, 2025. Essential for investors and stakeholders.

Biotech Sector Arbutus Biopharma 8-K Filing NASDAQ ABUS Corporate Events